MPS Powered by Eureka

Current Genomics

ISSN: 1389-2029 (Print)
eISSN: 1875-5488 (Online)

Current Genomics is a peer-reviewed journal that provides essential reading about the latest and most important developments in genome science and related fields of research. Systems biology, systems modeling, machine learning, network inference, bioinformatics, computational biology, epigenetics, single cell genomics, extracellular vesicles, quantitative biology, and synthetic biology for the study of evolution, development, maintenance, aging and that of human health, human diseases, clinical genomics and precision medicine are topics of particular interest. The journal covers plant genomics. The journal will not consider articles dealing with breeding and livestock. Current Genomics publishes three types of articles including: i) Research papers from internationally-recognized experts reporting on new and original data generated at the genome scale level. Position papers dealing with new or challenging methodological approaches, whether experimental or mathematical, are greatly welcome in this section. ii) Authoritative and comprehensive full-length or mini reviews from widely recognized experts, covering the latest developments in genome science and related fields of research such as systems biology, statistics and machine learning, quantitative biology, and precision medicine. Proposals for mini-hot topics (2-3 review papers) and full hot topics (6-8 review papers) guest edited by internationally-recognized experts are welcome in this section. Hot topic proposals should not contain original data and they should contain articles originating from at least 2 different countries. iii) Opinion papers from internationally recognized experts addressing contemporary questions and issues in the field of genome science and systems biology and basic and clinical research practices.

Special Issues With Active Call for Papers

Submission closes on: Dec 31, 2024
Genomic Insights into Oncology: Harnessing Machine Learning for Breakthroughs in Cancer Genomics.

This special issue aims to explore the cutting-edge intersection of genomics and oncology, with a strong emphasis on original data and experimental validation. While maintaining the focus on how machine learning and advanced data analysis techniques are revolutionizing our understanding and treatment of cancer, this issue will prioritize contributions that go beyond mere data-mining. We seek to include comprehensive review articles that synthesize recent advancements and research papers that present novel data, demonstrating clear experimental... see more

Submission closes on: Dec 31, 2024
Pathogen genomics & human health

Pathogens establish successful infection need to escape host immune surveillance. Alteration and mutation of genomics in pathogens confer advantages to subvert the host immune barrier. In this issue, we will collect and discuss current understanding in the field of “pathogen genomics and human disease”. see more

Submission closes on: Dec 31, 2024
Current Genomics in Cardiovascular Research

Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with genomics and cardiovascular disease. Experimental studies, network meta-analysis, randomized controlled trials, systematic reviews and meta-analysis, umbrella reviews, meta-epidemiologic studies, cross-sectional studies, diagnosis, treatment, management, prevention... see more

Submission closes on: Dec 04, 2024
Integrating Artificial Intelligence and Omics Approaches in Complex Diseases

Recent advancements in AI and omics methodologies have revolutionized the landscape of biomedical research, enabling us to extract valuable information from vast amounts of complex data. By combining AI algorithms with omics technologies such as genomics, proteomics, metabolomics, and transcriptomics, researchers can obtain a more comprehensive and multi-dimensional analysis of biological systems, ultimately leading to a better understanding of disease mechanisms. Complex diseases, characterized by their heterogeneous nature, pose unique challenges to researchers and clinicians... see more